APA (7th ed.) Citation

Yang, Y., Liu, Y., Qiao, W., Jin, W., Zhu, S., Yan, Y., . . . Xu, Q. (2024). Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren’s syndrome in mice by promoting TEC kinase degradation. Acta Pharmacologica Sinica, 45(9), 1926-1936. https://doi.org/10.1038/s41401-024-01288-7

Chicago Style (17th ed.) Citation

Yang, Ya-qi, Yi-jun Liu, Wen-xuan Qiao, Wei Jin, Shun-wei Zhu, Yu-xi Yan, Qiong Luo, and Qiang Xu. "Iguratimod Suppresses Plasma Cell Differentiation and Ameliorates Experimental Sjögren’s Syndrome in Mice by Promoting TEC Kinase Degradation." Acta Pharmacologica Sinica 45, no. 9 (2024): 1926-1936. https://doi.org/10.1038/s41401-024-01288-7.

MLA (9th ed.) Citation

Yang, Ya-qi, et al. "Iguratimod Suppresses Plasma Cell Differentiation and Ameliorates Experimental Sjögren’s Syndrome in Mice by Promoting TEC Kinase Degradation." Acta Pharmacologica Sinica, vol. 45, no. 9, 2024, pp. 1926-1936, https://doi.org/10.1038/s41401-024-01288-7.